首页 | 本学科首页   官方微博 | 高级检索  
     

放疗联合奈达铂同步治疗老年人头颈鳞癌的疗效分析
引用本文:王枫,李荣清,艾毅钦. 放疗联合奈达铂同步治疗老年人头颈鳞癌的疗效分析[J]. 江苏临床医学杂志, 2012, 0(1): 62-63
作者姓名:王枫  李荣清  艾毅钦
作者单位:昆明医学院第一附属医院放疗科,云南昆明650032
基金项目:中国高校医学期刊临床专项资金(11220003)
摘    要:目的评价放疗联合奈达铂化疗治疗老年人头颈鳞癌的疗效和毒副反应。方法对25例老年人头颈部鳞癌采用放疗同步每周联合小剂量奈达铂化疗,观察临床疗效及毒副反应情况。结果总有效率达为80%,1、2年生存率分别为72%、44%。治疗期间主要毒副反应为白细胞减少,口腔黏膜反应,恶心、呕吐及放射性脑损伤。结论放疗联合奈达铂同步治疗老年人头颈鳞癌具有较好疗效,毒副作用可耐受。

关 键 词:头颈鳞癌  奈达铂  放射治疗

Clinical analysis of synchronous radiotherapy combined with nedaplatin for head and neck squamous cell carcinoma in the elderly
WANG Feng,LI Rong-qing,AI Yi-qin. Clinical analysis of synchronous radiotherapy combined with nedaplatin for head and neck squamous cell carcinoma in the elderly[J]. Journal of Jiangsu Clinical Medicine, 2012, 0(1): 62-63
Authors:WANG Feng  LI Rong-qing  AI Yi-qin
Affiliation:(The First Hospital Affiliated to Kunming Medical College,Kunming,Yunnan,650032)
Abstract:Objective To evaluate the effect and adverse reactions of synchronous radiotherapy combined with nedaplatin for the elderly with head and neck squamous cell carcinoma(HNSCC).Methods Twenty-five elderly patients with HNSCC received the regimen of radiotherapy combined with low-dose of nedaplatin every week.The clinical effect and adverse reactions were observed.Results The total efficacy rate was 80%,and 1-and 2year survival rates were 72% and 44% respectively.The complications during treatment were leukopenia,oral mucosal response,nausea,vomiting and radiation-induced cerebral injury.Conclusion HNSCC has better effect and tolerable adverse reactions in the elderly.
Keywords:neck squamous carcinoma  nedaplatin  radiotherapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号